Navigation Links
Extended Antiviral May Benefit Kidney Transplant Patients
Date:9/17/2009

Risk of viral infection can be cut in half with 6 months of treatment, study finds

THURSDAY, Sept. 17 (HealthDay News) -- A longer period of preventive treatment after kidney transplant can help reduce the risk that the patient will become infected with a virus that can cause devastating problems, new research suggests.

Healthy people can usually fight off the virus, called cytomegalovirus, but those with kidney transplants have weakened immune systems and are more susceptible to infection, the authors of the study noted in a news release from the American Society of Nephrology.

In the comparison study, Dr. Fu Luan, of the University of Michigan in Ann Arbor, and colleagues gave kidney transplant patients either three months or six months of treatment with the antiviral drug valganciclovir. They found that those who were given the longer treatment had a rate of infection that was half that of those who received treatment for three months (12 percent vs. 24 percent).

When the researchers took into account other factors that could have played a role, they found that the longer treatment regimen lowered the risk of cytomegalovirus by nearly two-thirds.

The study also found that the longer treatment is cost-effective, although it is expensive. But the study authors contend that it's cheaper in the long run to prevent infections that could end up being very costly.

The findings appear online Sept. 17 in the Journal of the American Society of Nephrology.

More information

Learn more about kidney transplants from the U.S. National Library of Medicine.



-- Randy Dotinga



SOURCE: American Society of Nephrology, news release, Sept. 17, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product
2. FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
3. Deadline Extended for Nominations for Jay and Rose Phillips Awards and Phillips Caregiver Award
4. Shires INTUNIV (Guanfacine) extended release in children with ADHD and oppositional symptoms
5. FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
6. New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
7. Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
8. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress
9. Cipher receives tentative FDA approval for extended-release tramadol capsules
10. Bioniche Warrants Expiration Date to be Extended
11. Teaching Hospitals Post-Op Gains Not Extended to Blacks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Extended Antiviral May Benefit Kidney Transplant Patients
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley ... into Canada to provide its range of unique and advantaged protective solutions ... City that will provide bilingual customer service and marketing support. A new distribution ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance agency Dennis Fuller ... area, has initiated a fundraiser for a two year old little girl named ... Christmas. To support this beautiful child who is facing life’s journey without her ...
(Date:2/8/2016)... ... ... Remember the old saying “rub some dirt on it”? Perhaps you should try ... Clay” the health benefits of integrating clay into a daily diet are numerous, as ... motivational speaker, Perry A~ has since dedicated her life to learning about the benefits ...
(Date:2/8/2016)... ... ... the Rocky Mountain region’s longest running and impressive garden and home show where you ... the most incredible gardens and home improvement experts that attend this amazing show. ... 700 14th St. Denver CO, is an exciting event that Performance Mobility has enjoyed ...
(Date:2/8/2016)... Overland Park, KS (PRWEB) , ... February 08, 2016 , ... ... Oils, a leader in Mole removal products. , Moles are derived from a cluster ... can appear in all the wrong places and create a lifetime of embarrassment. Historically, ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today ... ended December 31, 2015, the Company achieved revenue of $8,195,839, ... same quarter in fiscal 2015. --> ... fiscal year 2016 was $2,068,635, or $.03 per share, up ... share, in the Q2 of fiscal year 2015. Gross margin ...
(Date:2/8/2016)... http://www.researchandmarkets.com/research/bcrl3s/labelfree ) ... "Label-Free Detection Market by Technology, Products, Applications ... to their offering. --> http://www.researchandmarkets.com/research/bcrl3s/labelfree ... "Label-Free Detection Market by Technology, Products, ... report to their offering. --> ...
(Date:2/8/2016)... 2016  HemaFlo Therapeutics, Inc. announced today that the United ... Number 9,119,880 covering the use of NephroFlow to treat acute ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Peterson , PhD, HemaFlo,s founder, said, "We are pleased to ... --> Dale Peterson , PhD, HemaFlo,s founder, said, ...
Breaking Medicine Technology: